Table 1 Characteristics of the GBM samples used in our cohort for TMAs generation
From: Immune landscapes associated with different glioblastoma molecular subtypes
Variable | N | % of cohort | Median survival (months) | Log-rank Mantel-Cox test |
|---|---|---|---|---|
Gender | * | |||
Males | 56 | 57.1 | 12 | |
Females | 42 | 42.9 | 12 | |
Age | *** | |||
< 40 | 3 | 3.1 | Undefined | |
41–60 | 42 | 42.9 | 12 | |
61–80 | 48 | 48.9 | 11 | |
> 80 | 5 | 5.1 | 4 | |
IDH1 R132H mutation | *** | |||
Positive | 4 | 4.1 | Undefined | |
Negative | 94 | 95.9 | 12 | |
Molecular subtype | ||||
Classical | 24 | 24.5 | 12.5 | |
Mesenchymal | 26 | 26.5 | 9.5 | |
Neural | 22 | 22.5 | 15.5 | |
Proneural | 26 | 26.5 | 10 | |